MTNB icon

Matinas BioPharma
MTNB

Overview Fund Activity

51 hedge funds and large institutions have $9.31M invested in Matinas BioPharma in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 4 closing their positions.

Holders
51
Holders Change
+1
Holders Change %
+2%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
14
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wells Fargo
1
Wells Fargo
California
$204K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$705K
3
VF
3
Virtu Financial
New York
$33K
4
BlackRock
4
BlackRock
New York
$903K
5
Commonwealth Equity Services
5
Commonwealth Equity Services
Massachusetts
$18K

Top Sellers

1
NRS
1
Neville Rodie & Shaw
New York
$417K
2
BCM
2
Bridgeway Capital Management
Texas
$70.7K
3
SIG
3
Sargent Investment Group
Maryland
$1.41M
4
Millennium Management
4
Millennium Management
New York
$6.4K
5
Jane Street
5
Jane Street
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
51
IFP Advisors
Florida
$231 – – –
Jane Street
52
Jane Street
New York
– -$27.2K -1,159 Closed
Susquehanna International Group
53
Susquehanna International Group
Pennsylvania
– -$6.93K -295 Closed
FAIM
54
Financial Advocates Investment Management
Washington
– -$4.7K -200 Closed
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
– -$37 -2 Closed
Bank of America
56
Bank of America
North Carolina
– -$3 – –
1 2
3